December 6, 2008FDA sets melamine standard for baby formula - San Francisco Examiner FDA sets melamine standard for baby formula - San Francisco Examiner
» 7 hrs ago: FDA sets melamine standard for baby formula « 19 hrs ago: FDA sets safe level for infant formula contaminant Chemist Michael Filigenzi demonstrates how vials of liquefied pet food are placed in trays for testing for the industrial Source: www.examiner.com 'FDA special agent' calls are frauds - Baltimore Sun Beware of an extortion scheme by callers who falsely identify themselves as "FDA special agents" or other FDA officials, according to the U.S. Food and Drug Administration. Several cases have been reported of callers enticing consumers to purchase Source: www.baltimoresun.com WHO expert panel says food should contain no melamine, but that small - Chicago Tribune WHO expert panel says food should contain no melamine, but that small - Chicago Tribune
GENEVA (AP) — The World Health Organization said Friday that tiny traces of the chemical melamine are not harmful in most foods, but it joined the U.S. and EU in setting a strict limit that regulators should impose before pulling products off the Source: www.chicagotribune.com Eyelash growth drug backed - The Daily Advertiser Allergan, which makes Botox anti-wrinkle injections, has asked the Food and Drug Administration to approve its Lumigan formula to enhance eyelashes for patients 18 and older. The agency's panel of outside eye and skin specialists voted unanimously Source: www.theadvertiser.com Rituxan in Combination with Chemotherapy Improves Progression-Free - Genetic Engineering News Genentech, Inc. ( NYSE:DNA ) and Biogen Idec ( Nasdaq:BIIB ) today announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan ® (rituximab) plus chemotherapy significantly increased the time Source: www.genengnews.com Incyte's Selective JAK1 / 2 Inhibitor, INCB18424, Demonstrates Rapid - Finanz Nachrichten Incyte Corporation ( News ) (Nasdaq: INCY) will present updated results from an ongoing Phase II trial of INCB18424, its selective, orally available Janus kinase (JAK) inhibitor, in patients with myelofibrosis (MF) at the 50th American Society of Source: www.finanznachrichten.de FDA: Risks of new asthma drugs vary - Newsday The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said Friday. But a less widely used medication, Serevent, had a significantly Source: www.newsday.com Many Countries Ban Imports of Chinese Dairy Products - The Epoch Times Several incidents of melamine contamination this year have noticeably harmed China’s diary industry. According to official government statistics, export of Chinese dairy decreased 92 percent in October 2008 compared to the same period last year. A Source: en.epochtimes.com AstraZeneca's new lung drug may face US delay - KIDK AstraZeneca's new lung drug may face US delay - KIDK
LONDON (AP) - AstraZeneca PLC could have to delay the rollout of its new infant lung drug in the United States because the Food and Drug Administration has asked for more information about the medicine before allowing it on the market. AstraZeneca Source: www.kidk.com GlaxoSmithKline: Study Shows Promacta Aids Blood Condition - Beurs.nl GlaxoSmithKline PLC (GSK) said Saturday that a recent long-term study of its new drug to treat a blood condition showed positive results. The Food and Drug Administration last month granted accelerated approval to the drug, Promacta. The FDA's Source: www.beurs.nl FDA: Risks of new asthma drugs vary - PhysOrg But a less widely used medication, Serevent, had a significantly higher rate of complications when compared to older treatments, the Food and Drug Administration said. Both drugs are made by the same company, GlaxoSmithKline. FDA safety reviewers are Source: www.physorg.com Risks for new asthma drugs vary, FDA warns - TriVallyCentral WASHINGTON - The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said Friday. But a less widely used medication, Serevent, had a Source: www.zwire.com WHO limits melamine in food, says traces seem safe - Philadelphia Inquirer GENEVA - The World Health Organization said Friday that tiny traces of the chemical melamine are not harmful in most foods, but it joined the U.S. and EU in setting a strict limit that regulators should impose before pulling products off the shelf Source: www.philly.com Beware of Extortion Scam by FDA Impersonators Beware of Extortion Scam by FDA Impersonators
As part of a fraudulent scheme to extort money, callers have falsely identified themselves as "FDA special agents" or other FDA officials. FDA Approves Toviaz, a New Drug to Treat Overactive Bladder The U.S. Food and Drug Administration has approved a new drug to help patients suffering from overactive bladder (OAB). Toviaz (fesoterodine fumarate) works by relaxing the smooth muscle tissue of the bladder, thus reducing the urinary frequency, urge to urinate, and sudden urinary incontinence (leakage of urine), that are characteristic symptoms of OAB. FDA Announces Participants of Pilot Program for Third-Party Certification of Imported Aquacultured Shrimp The U.S. Food and Drug Administration today announced the participants in Phase II of its pilot program for voluntary third-party certification programs for imported aquacultured shrimp. Improper Use of Decorative Contacts May Haunt You Halloween is a good time to remind people that improper use of non-prescription decorative contact lenses may harm your vision Business briefs - Democrat and Chronicle Business briefs - Democrat and Chronicle
Brighton technology firm Impact Technologies LLC has purchased a Pennsylvania company, RLW Inc., which specializes in wireless remote monitoring devices. The purchase price was not disclosed. RLW employs 30 and will remain in Pennsylvania, operating Source: www.democratandchronicle.com Nigeria bans teething drug after 25 children die - Guardian Unlimited Associated Press Writer= LAGOS, Nigeria (AP) - Teething formula tainted with a toxic thickening agent has killed 25 children in Nigeria, prompting regulators to yank it from shelves and shut down its manufacturer, officials said Wednesday. The Source: www.guardian.co.uk AstraZeneca to make case for Symbicort - Delaware Online AstraZeneca next week will defend the drug Symbicort to a Food and Drug Administration advisory board after an agency analysis found that some asthma drugs pose a higher risk of hospitalizations and deaths. The FDA analyzed clinical trial data from Source: www.delawareonline.com AstraZeneca to make case for Symbicort - Delaware Online The FDA analyzed clinical trial data from four drugs -- Symbicort, Advair, Foradil and Serevent -- in advance of an advisory committee meeting scheduled for Wednesday and Thursday. The agency has been reviewing the safety of medications known as long Source: www.delawareonline.com Roche to sell arthritis drug in India ahead of US, Europe approval - Business Standard Roche expects to start selling Actemra by April 2009, company sources said. India will be the second country to launch the drug, Japan being the first. The Indian drug regulator Drug Controller General of India (DCGI) usually approves a new drug Source: www.business-standard.com New asthma drugs raise concern - Boston Globe WASHINGTON - The blockbuster asthma drug Advair does not appear to have an increased risk of serious respiratory complications seen with similar new medicines, federal health officials said yesterday. But a less widely used medication, Serevent, had Source: www.boston.com FDA panel backs Allergan's eyelash enhancing drug - Los Angeles Daily News Allergan, which makes Botox anti-wrinkle injections, has asked the Food and Drug Administration to approve its Lumigan formula to enhance eyelashes for patients 18 and older. WASHINGTON - A panel of government experts said Friday a glaucoma drug from Source: www.dailynews.com December 5, 2008FDA Approves New Drug to Treat Severe Form of Epilepsy FDA Approves New Drug to Treat Severe Form of Epilepsy
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. FDA, EPA and USDA Conclude That Accidental Release of Genetically Engineered Cotton Poses No Safety Risk to Humans or Animals The U.S. government announced today that there is no food or feed safety concern from an incident in which a small portion of an unauthorized genetically engineered (GE) cotton variety was harvested along with commercially available GE cotton. Nonna's Real Italiana Cuccine Issues an Allergy Alert on Undeclared Milk, Soy, and Wheat in Stuffed Artichokes (October 22) This product is distributed through retailers in the Greater New Orleans area including the Northshore from October 8, 2008 to October 17, 2008. The product is individually wrapped in clear plastic wrap bearing the label: "STUFFED ARTICHOKE, Net Wt. 15 oz., NONNA'S REAL ITALIANA CUCCINE". Starcaps Dietary Supplement Capsules Recall due to undeclared drug, Bumetanide, resulting in drug interactions including risk of hypotension (low blood pressure), or fainting (syncope). FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer The five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium were seized at the FDA's request by U.S. Marshals. These products, which were manufactured from material imported from China, had been found by the agency to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin's anticoagulant activity. Erythropoiesis Stimulating Agents (ESAs) - Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp) Erythropoiesis Stimulating Agents (ESAs) - Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)
(UPDATE) FDA issued Q and As for recently approved Medication Guides. Phenytoin (marketed as Dilantin, Phenytek and generics) and Fosphenytoin Sodium (marketed as Cerebyx and generics) Potential increased risk of serious skin reactions, including Stevens Johnson syndrome and toxic epidermal necrolysis, from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen allele, HLA-B*1502. Keeping Watch Over Direct-to-Consumer Ads FDA regulates direct-to-consumer advertising for prescription drugs, working to ensure that ads are truthful, balanced, and accurate. FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer The five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium were seized at the FDA's request by U.S. Marshals. These products, which were manufactured from material imported from China, had been found by the agency to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin's anticoagulant activity. PANOS Brands Recalls Vegan Rella Cheddar Block (November 21) PANOS Brands Recalls Vegan Rella Cheddar Block (November 21)
PANOS brands, of Saddle Brook, NJ is recalling Vegan Rella Cheddar Block, (a cheese substitute) with a Sell by date of 12/09/2008. Wegmans Food Markets, Inc. Issues Voluntary Recall on Wegmans Italian Classics Seasoned Tomato Sauce (November 20) Wegmans Food Markets, Inc. is initiating a voluntary recall of 24 oz. Wegmans Italian Classics Seasoned Tomato Sauce with a "use-by- date of 11/26/08", UPC 77890 79010. Drug Shortages: Resolved Drug Shortages; Zanosar (Streptozocin) 1gm/vial Injection See Web site for additional information Benzoyl Peroxide Acne Cream 10% marked as: DG Maximum Strength Acne Medicated Gel; Kroger Acne Gel 10% Benzoyl Peroxide Acne Medication; Equate: Medicated Acne Gel Benzoyl Peroxide Acne Cream 10% marked as: DG Maximum Strength Acne Medicated Gel; Kroger Acne Gel 10% Benzoyl Peroxide Acne Medication; Equate: Medicated Acne Gel
Voluntary recall due to samples of the products containing Burkholderia Cepacia bacteria. Phenytoin (marketed as Dilantin, Phenytek and generics) and Fosphenytoin Sodium (marketed as Cerebyx and generics) Potential increased risk of serious skin reactions, including Stevens Johnson syndrome and toxic epidermal necrolysis, from phenytoin therapy in Asian patients positive for a particular human leukocyte antigen allele, HLA-B*1502. Recalls and Safety Alerts: Problems with Medtronic Intrathecal Catheters Medtronic has alerted healthcare professionals about the potential for misconnections between certain sutureless intrathecal catheters and the implanted infusion pumps to which they're attached. The four affected products are: ? INDURA 1P Intrath... Infants' Mylicon Gas Relief Dye Free Drops (Simethicone-Antigas) Product recalled because some bottles of the product could include metal fragments. Animas Corporation Battery Caps Used with the OneTouch Ping System, Animas 2020 Insulin Pump, Animas IR1200 Insulin Pump, and Animas IR1250 Insulin Pump Potential for device to stop administering insulin, resulting in hyperglycemia or hypoglycemia. FDA Approves New Drug to Alleviate Moderate to Severe Pain The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain. December 2008 Patient Safety News Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients. FDA, EPA and USDA Conclude That Accidental Release of Genetically Engineered Cotton Poses No Safety Risk to Humans or Animals The U.S. government announced today that there is no food or feed safety concern from an incident in which a small portion of an unauthorized genetically engineered (GE) cotton variety was harvested along with commercially available GE cotton. FDA Approves New Drug to Treat Severe Form of Epilepsy FDA Approves New Drug to Treat Severe Form of Epilepsy
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. Erythropoiesis Stimulating Agents (ESAs) - Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp) (UPDATE) FDA issued Q and As for recently approved Medication Guides. FDA Seizes Contaminated Heparin from a Cincinnati Manufacturer The five lots of Heparin Sodium Active Pharmaceutical Ingredient (API) and six lots of Heparin Lithium were seized at the FDA's request by U.S. Marshals. These products, which were manufactured from material imported from China, had been found by the agency to be contaminated with over-sulfated chondroitin sulfate (OSCS), a substance that mimics heparin's anticoagulant activity. Drug Shortages: Drugs to be Discontinued; Mitozytrex (Mitomycin for Injection) See Web site for additional information. Benzoyl Peroxide Acne Cream 10% marked as: DG Maximum Strength Acne Medicated Gel; Kroger Acne Gel 10% Benzoyl Peroxide Acne Medication; Equate: Medicated Acne Gel Voluntary recall due to samples of the products containing Burkholderia Cepacia bacteria. December 4, 2008Food Safety Tips for Healthy Holidays Food Safety Tips for Healthy Holidays
FDA gives consumers practical food safety tips to help prevent foodborne illness. Beware of Extortion Scam by FDA Impersonators As part of a fraudulent scheme to extort money, callers have falsely identified themselves as "FDA special agents" or other FDA officials. Keeping Watch Over Direct-to-Consumer Ads FDA regulates direct-to-consumer advertising for prescription drugs, working to ensure that ads are truthful, balanced, and accurate. FDA Acts to Reduce Risk of Salmonella Infections Find out why pet turtles may be a health risk and how FDA is enforcing a ban on the small creatures. Drug Shortages: Resolved Drug Shortages; Vinblastine Sulfate Injection See Related information section FDA Partners With WebMD to Better Serve Consumers FDA and WebMD have formed a new partnership to expand access to timely and reliable consumer health information. Addressing Questions About Gardasil FDA addresses the safety of Gardasil, a vaccine that prevents infection with types of human papillomavirus (HPV) Drug Shortages: Resolved Drug Shortages; MVI Adult Injectable No further supply issues are anticipated Drug Shortages: Drugs to be Discontinued; Mitozytrex (Mitomycin for Injection) See Web site for additional information. Using Medicare To Solve The Social Security Problem - Libertymaven.com Using Medicare To Solve The Social Security Problem - Libertymaven.com
The FDA has come up with a solution to solve America’s Social Security funding problem and they may or may not be aware of it. Oddly, they propose using Medicare funds to help with the problem. What could I possibly mean by this? Well, I admit it Source: libertymaven.com Top FDA Official Says Avandia Should Remain Available - Wall Street Journal GlaxoSmithKline PLC's diabetes drug Avandia should remain available to patients despite some medical associations' calls for doctors not to use it, a top official of the Food and Drug Administration said. Janet Woodcock, head of the FDA's Center for Source: online.wsj.com FDA Approvals: Apriso, Promacta, Treanda CME - Medscape News Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) ™ for physicians; Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians To participate in this internet activity: (1) review the target audience, learning objectives, and Source: www.medscape.com BD Receives FDA Approval for the BD FocalPoint(TM) GS Imaging System - PR Newswire BURLINGTON, N.C., Dec. 4 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX) , announced today that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint Source: sev.prnewswire.com US objects to AstraZeneca schizophrenia drug pitch - Forbes WASHINGTON (Reuters) - U.S. regulators complained that an AstraZeneca PLC sales representative suggested an unapproved use of the company's schizophrenia drug Seroquel to a physician, according to a letter released Thursday. The Food and Drug Source: www.forbes.com BD Diagnostics Gets FDA's Pre-Market Approval For BD FocalPoint GS - RTT News (RTTNews) - Thursday, BD Diagnostics, a segment of Becton, Dickinson and Company (BDX: News ), said that it has received pre-market approval from U.S. Food And Drug Administration or FDA, for the BD FocalPoint GS Imaging System, a tool designed to Source: www.rttnews.com BD Receives FDA Approval for the BD FocalPoint(TM) GS Imaging System - Carolina Newswire BD Receives FDA Approval for the BD FocalPoint(TM) GS Imaging System - Carolina Newswire
BURLINGTON, N.C. --BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) for the BD FocalPoint(TM) GS Imaging System. This Source: carolinanewswire.com Allergan shares rise on eyelash drug outlook - Forbes Shares of Allergan Inc. gained ground Thursday as Wall Street forecast a positive regulatory review for the use of glaucoma drug Lumigan as a treatment for longer and fuller eyelashes. The maker of eye care products, breast implants, and anti-wrinkle Source: www.forbes.com Technology Pioneer 2009 - AC Immune Highlights Significant Clinical - Phramalive.com LAUSANNE, Switzerland, December 04, 2008 /PRNewswire/ -- AC Immune SA, a leader in Alzheimer's disease drug development, announced today that the World Economic Forum has elected AC Immune as Technology Pioneer 2009 for its accomplishments as an Source: www.pharmalive.com Drug Marketing Techniques May Be Risking Patient Safety - Science Daily ScienceDaily (Dec. 4, 2008) — With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever before, patients' safety is being compromised, warns a study published on bmj.com. Dr David Kao from the Source: www.sciencedaily.com Consumer group questions online medical device ads - Kalamazoo Gazette WASHINGTON -- A consumer watchdog group on Wednesday questioned the legality of several advertisements for medical devices that appear on YouTube and called on regulators to crack down on the promotions. Online videos from Abbott Laboratories Source: www.mlive.com Tesetaxel, a Leading Oral Taxane in Clinical Development, Receives FDA - Businesswire.com BERKELEY HEIGHTS, N.J.--( BUSINESS WIRE )--Genta Incorporated (OTCBB: GNTA) announced today that the Company has received notice from the U.S. Food and Drug Administration (FDA) that tesetaxel, the Company’s oral taxane in clinical development, has Source: www.businesswire.com FDA Statement on Release of Bisphenol A (BPA) Subcommittee Report FDA Statement on Release of Bisphenol A (BPA) Subcommittee Report
The subcommittee report to the Science Board raises important questions regarding the draft safety assessment, and the FDA looks forward to the review of the subcommittee's report by the Science Board on Oct 31. Innohep (tinzaparin sodium injection) Clinical study stopped early because of interim finding of increase in all-cause mortality in patients who received Innohep. FDA, EPA and USDA Conclude That Accidental Release of Genetically Engineered Cotton Poses No Safety Risk to Humans or Animals The U.S. government announced today that there is no food or feed safety concern from an incident in which a small portion of an unauthorized genetically engineered (GE) cotton variety was harvested along with commercially available GE cotton. Safety Concerns and Labeling Changes for Psoriasis Drug Raptiva FDA has received reports of serious infections leading to hospitalizations and deaths in people who use Raptiva. FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid The U.S. Food and Drug Administration today issued an expedited approval of a supplemental application that allows for changes in the manufacturing of Sucraid (sacrosidase) Oral Solution. Zhen De Shou Fat Loss Capsules Recall due to undeclared sibutramine, an appetite suppressant known to substantially increase blood pressure and/or pulse rate in some patients. FDA Announces Participants of Pilot Program for Third-Party Certification of Imported Aquacultured Shrimp The U.S. Food and Drug Administration today announced the participants in Phase II of its pilot program for voluntary third-party certification programs for imported aquacultured shrimp. FDA Approves New Drug to Alleviate Moderate to Severe Pain The U.S. Food and Drug Administration has approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain. Drug Shortages: Drugs to be Discontinued; Cefotan (cefotetan injection)- updated Drug Shortages: Drugs to be Discontinued; Cefotan (cefotetan injection)- updated
See additional information in Related Information section. Recalls and Safety Alerts: Filter Ammonul to Remove Particulates Ucyclyd Pharma is notifying healthcare professionals that particulate matter has been detected in Ammonul Injection. Ammonul is used as an adjunct in treating hyperammonemia in certain patients with urea cycle disorders. The company says that the... December 3, 2008UPDATE 2-Pozen pain drug meets main goal in late-stage trial - Reuters UPDATE 2-Pozen pain drug meets main goal in late-stage trial - Reuters
BANGALORE, Dec 3 (Reuters) - Pharmaceutical company Pozen Inc (POZN.O: Quote , Profile , Research , Stock Buzz ) said its experimental pain drug for arthritis, PN 400, met the main goal of a late-stage trial. The trial's main goal, which is currently Source: www.reuters.com Drug Shortages: Current Drug Shortages; Ultra-TechneKow DTE (Technetium Tc 99m Generator) NDA 17-243 Drug Shortages: Current Drug Shortages; Ultra-TechneKow DTE (Technetium Tc 99m Generator) NDA 17-243
See Related information section for updated Letter from Mallinckrodt Drug Shortages: Current Drug Shortages; Vinblastine Sulfate Injection See Related information section for posted letter Drug Shortages: Drugs to be Discontinued; SecreFlo (porcine secretin for injection, 16 mcg/vial) See Related information section Drug Shortages: Drugs to be Discontinued; Mitozytrex (Mitomycin for Injection) Drug Shortages: Drugs to be Discontinued; Mitozytrex (Mitomycin for Injection)
See Web site for additional information. Drug Shortages: Drugs to be Discontinued; Nimotop (nimodipine) capsules See Web site for additional information FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes (November 5) The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling. The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death. Drug Shortages: Current Drug Shortages; Levoleucovorin (Fusilev) 50 mg single use vials See Web site for additional information Fashion Sanctuary Issues a Voluntary Nationwide Recall of All Lots of Zhen De Shou Fat Loss Capsules Found to Contain an Undeclared Drug Ingredient (November 23) Fashion Sanctuary is recalling all lot codes of Zhen De Shou Fat Loss Capsules sold in 10 count blister cards. Drug Shortages: Current Drug Shortages; Ultra-TechneKow DTE (Technetium Tc 99m Generator) NDA 17-243 See Web site for additional information on this current drug shortage Drug Shortages: Resolved Drug Shortages; Vinblastine Sulfate Injection Drug Shortages: Resolved Drug Shortages; Vinblastine Sulfate Injection
See Related information section Drug Shortages: Resolved Drug Shortages; Fentanyl transdermal patch See Related information section Drug Shortages: Current Drug Shortages; Leucovorin See web site for additional information Drug Shortages: Drugs to be Discontinued; SecreFlo (porcine secretin for injection, 16 mcg/vial) See Web site for additional information Nestle Withdraws Nestle Farinha Lactea Cereal in the United States (November 3) Nestle is withdrawing Nestle Farinha Lactea cereal in the United States. Nestle is taking this action as we have learned that the product may contain residual traces of a pesticide not currently approved for use on wheat in the U.S. While the pesticide is approved for use in Brazil and the noted levels are well below Brazilian standards, it is not used on wheat products in the United States and therefore there is no set standard for its presence in cereal. The pesticide is permitted in the United States on grain crops other than wheat. Drug Shortages: Current Drug Shortages; Vinblastine Sulfate Injection See Related information section for posted letter Fashion Sanctuary Issues a Voluntary Nationwide Recall of All Lots of Zhen De Shou Fat Loss Capsules Found to Contain an Undeclared Drug Ingredient (November 23) Fashion Sanctuary is recalling all lot codes of Zhen De Shou Fat Loss Capsules sold in 10 count blister cards. Drug Shortages: Drugs to be Discontinued; Cefotan (cefotetan injection)- updated See additional information in Related Information section. December 2, 2008Managing Drug-Drug Interaction Risks CME/CE - Medscape News Managing Drug-Drug Interaction Risks CME/CE - Medscape News
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s) ™ for physicians; Nurses - 1.0 ANCC contact hours (1.0 contact hours are in the area of pharmacology); Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs) To Source: www.medscape.com Nigerian death toll rises in tainted formula case - Denver Post LAGOS, Nigeria—Nigerian food and drug regulators on Tuesday updated the death toll to 34 in an outbreak of fatalities among infants given a locally-made teething formula tainted with a toxic thickening agent. When the outbreak was first reported Source: www.denverpost.com Stevia: The 'Holy Grail' of sweeteners? - WPVI WASHINGTON, D.C.; December 2, 2008 -- The U.S. Food and Drug Administration is expected to soon decide the future of what some in the food industry are calling the holy grail of sweeteners - stevia. It is a low-calorie, natural substance derived from Source: abclocal.go.com FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid
The U.S. Food and Drug Administration today issued an expedited approval of a supplemental application that allows for changes in the manufacturing of Sucraid (sacrosidase) Oral Solution. Health Information Advisory on Infant Formula In response to reports of contaminated milk-based infant formula manufactured in China, FDA issued a Health Information Advisory on September 12, 2008. Keeping Watch Over Direct-to-Consumer Ads FDA regulates direct-to-consumer advertising for prescription drugs, working to ensure that ads are truthful, balanced, and accurate. Avoiding Drug Interactions Be careful about the three main types of interactions: drugs with food and beverages, drugs with dietary supplements, and drugs with other drugs. Improper Use of Decorative Contacts May Haunt You Halloween is a good time to remind people that improper use of non-prescription decorative contact lenses may harm your vision HHS/FDA Grants Tentative Approval for 75th Generic Anti-Retroviral Drug as Part of President's Emergency Plan for AIDS Relief Marketed by Macleods Pharmaceuticals, Ltd, of Kachigam, Daman, in the Republic of India, the 75th drug is 150 milligram and 300 milligram tablets of generic lamivudine, a nucleoside analog reverse-transcriptase inhibitor (nRTI), which blocks an enzyme called reverse transcriptase, important to HIV production. HIV-infected patients who take lamivudine with other anti-HIV treatments develop less opportunistic infections. Draft Guidance on Genetically Engineered Animals The technology of genetic engineering offers many benefits for health, agriculture, and the environment. FDA tells how it is regulating genetically engineered animals. FDA Acts to Reduce Risk of Salmonella Infections Find out why pet turtles may be a health risk and how FDA is enforcing a ban on the small creatures. FDA Warns Bayer About Two Unapproved Aspirin Products FDA has sent warning letters to Bayer HealthCare regarding two over-the-counter products that combine aspirin with a dietary supplement into a single pill. UPDATE 2-Data supports Novartis malaria drug -US FDA staff - Forbes UPDATE 2-Data supports Novartis malaria drug -US FDA staff - Forbes
WASHINGTON, Dec 1 (Reuters) - Data show Novartis (nyse: NVS - news - people ) AG's combination malaria drug Coartem appears to work and causes few serious side effects, U.S. Food and Drug Administration regulatory staff said in documents released on Source: www.forbes.com Thermo Fisher Scientific Launches Program to Meet Melamine Detection - WebitPR SAN JOSE, Calif. (December 2, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, announced it has launched a program focused on assisting government and commercial food testing laboratories in the development and Source: www.webitpr.com FDA speeds up review of Cell Therapeutics drug - Seattle Business Journal The Food and Drug Administration will expedite its review of whether the cancer drug Zevalin can be used in wider applications. Zevalin is being developed by RIT Oncology LLC, a joint venture of Cell Therapeutics Inc. (NASDAQ: CTIC), of Seattle, and Source: seattle.bizjournals.com Study Calls for Greater Scrutiny of 'Off-Label' Drug Use - Atlanta Journal Constitution Study Calls for Greater Scrutiny of 'Off-Label' Drug Use - Atlanta Journal Constitution
MONDAY, Nov. 24 (HealthDay News) -- It's called "off-label" prescribing, and it's the common practice of doctors prescribing a drug to treat a disease or condition that's different from the one studied by federal regulators that led to the drug's Source: www.ajc.com FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review - Phramalive.com SEATTLE, December 01, 2008 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Source: www.pharmalive.com Traces of Melamine Found in U.S.-Made Infant Formula - Wall Street Journal WASHINGTON -- The Food and Drug Administration said that it found one positive sample of U.S.-made infant formula containing melamine "at very low trace levels." Stephen Sundlof, director of the FDA's Center for Food Safety and Applied Nutrition Source: online.wsj.com Medicaid Pays Millions for Unapproved Drugs - Medheadlines.com As many as 72 million prescriptions each year are written for drugs that never received approval from the US Food and Drug Administration (FDA), costing US taxpayers, by way of the Medicaid program, more than $200 million since 2004, according to Source: medheadlines.com Data supports Novartis malaria drug -US FDA staff - Guardian Unlimited WASHINGTON, Dec 1 (Reuters) - Data show Novartis AG's combination malaria drug Coartem appears to work and causes few serious side effects, U.S. Food and Drug Administration regulatory staff said in documents released on Monday. The Swiss drugmaker Source: www.guardian.co.uk Medicis, Impax settle acne drug dispute - Forbes Medicis Pharmaceutical Corp. said Tuesday it cut a deal with potential competitor Impax Laboratories Inc. that ends a patent dispute over a generic version of the acne drug Solodyn and has the companies developing a more advanced version of the Source: www.forbes.com NicOx Signs Agreement With DSM for the Commercial Manufacture of - PR Newswire SOPHIA ANTIPOLIS, France, December 2 /PRNewswire/ -- NicOx S.A. (NYSE: COX) (Euronext: COX) (Paris: COX) today announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active Source: sev.prnewswire.com FDA Approves New Drug to Treat Severe Form of Epilepsy FDA Approves New Drug to Treat Severe Form of Epilepsy
The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. HHS/FDA Grants Tentative Approval for 75th Generic Anti-Retroviral Drug as Part of President's Emergency Plan for AIDS Relief Marketed by Macleods Pharmaceuticals, Ltd, of Kachigam, Daman, in the Republic of India, the 75th drug is 150 milligram and 300 milligram tablets of generic lamivudine, a nucleoside analog reverse-transcriptase inhibitor (nRTI), which blocks an enzyme called reverse transcriptase, important to HIV production. HIV-infected patients who take lamivudine with other anti-HIV treatments develop less opportunistic infections. FDA Reports Significant Progress in Protecting the Food Supply The U.S. Food and Drug Administration today released a report on its implementation of the Food Protection Plan that was launched a year ago to protect both domestic and imported food from accidental and intentional contamination. The Plan, which outlines strategies for prevention, intervention and response, is designed to address food safety and food defense for both domestic and imported products and covers the full lifecycle of food, by encouraging the building of safety into every step of the food supply chain. Improper Use of Decorative Contacts May Haunt You Halloween is a good time to remind people that improper use of non-prescription decorative contact lenses may harm your vision Preventing Medical Errors: Drug Name Confusion: Ephedrine and Epinephrine The Institute for Safe Medication Practices (ISMP) is warning again about the possibility of mix-ups between ephedrine and epinephrine. Not only do the names of these drugs look and sound similar, but since they're both used as vasopressors and vaso... Using Over-the-Counter Cough and Cold Products in Children FDA supports the voluntary actions of drug manufacturers to better inform consumers about the safe and effective use of over-the-counter cough and cold medicines in children. Addressing Questions About Gardasil FDA addresses the safety of Gardasil, a vaccine that prevents infection with types of human papillomavirus (HPV) Preventing Medical Errors: Removing Insulin from Cartons The Institute for Safe Medication Practices warns that storing insulin vials inside their cardboard cartons after the packages have been opened can be a medical emergency waiting to happen. If the vial is accidentally returned to the wrong carton af... Recalls and Melamine Contamination FDA has increased inspections and product testing in response to the melamine contamination problem that originated in Chinese dairy products. FDA Approves Toviaz, a New Drug to Treat Overactive Bladder The U.S. Food and Drug Administration has approved a new drug to help patients suffering from overactive bladder (OAB). Toviaz (fesoterodine fumarate) works by relaxing the smooth muscle tissue of the bladder, thus reducing the urinary frequency, urge to urinate, and sudden urinary incontinence (leakage of urine), that are characteristic symptoms of OAB. Improper Use of Decorative Contacts May Haunt You Improper Use of Decorative Contacts May Haunt You
Halloween is a good time to remind people that improper use of non-prescription decorative contact lenses may harm your vision Use Caution With Ayurvedic Products The presence of heavy metals in some Ayurvedic products makes them potentially harmful. Preventing Medical Errors: Recognizing Warfarin Brand Names A recent report by the Institute for Safe Medication Practices (ISMP) notes that some health professionals and patients may not realize that Jantoven is a brand name for the drug warfarin. That could result in inadvertently prescribing and dispensin... Keeping Watch Over Direct-to-Consumer Ads FDA regulates direct-to-consumer advertising for prescription drugs, working to ensure that ads are truthful, balanced, and accurate. Addressing Questions About Gardasil FDA addresses the safety of Gardasil, a vaccine that prevents infection with types of human papillomavirus (HPV) Vaccines Stand Ready for Flu Season FDA has approved six vaccines for the 2008-2009 flu season. December 2008 Patient Safety News Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients. FDA Warns Public of Extortion Scam by FDA Impersonators FDA Warns Public of Extortion Scam by FDA Impersonators
The U.S. Food and Drug Administration is warning consumers about a fraudulent scheme to extort money from consumers by callers who falsely identify themselves as "FDA special agents" or other FDA officials. FDA Acts to Reduce Risk of Salmonella Infections Find out why pet turtles may be a health risk and how FDA is enforcing a ban on the small creatures. December 1, 2008Data supports Novartis malaria drug -US FDA staff - Guardian Unlimited Data supports Novartis malaria drug -US FDA staff - Guardian Unlimited
WASHINGTON, Dec 1 (Reuters) - Data show Novartis AG's combination malaria drug Coartem appears to work and causes few serious side effects, U.S. Food and Drug Administration regulatory staff said in documents released on Monday. The Swiss drugmaker Source: www.guardian.co.uk U.S FDA Grants Pralatrexate Orphan Drug Designation for the Treatment - PR Inside www.allos.com/ - Allos Therapeutics, Inc. (Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.S. Food and Drug Source: www.pr-inside.com Novartis Malaria Drug Safe, Effective: FDA - Post Chronicle Novartis Malaria Drug Safe, Effective: FDA - Post Chronicle
Data show Novartis AG's combination malaria drug Coartem appears to work and causes few serious side effects, U.S. Food and Drug Administration regulatory staff said in documents released on Monday. "The majority of AEs (adverse events) were of mild Source: www.postchronicle.com White Paper Addresses FDA Approval Challenges Facing Combination - Phramalive.com AGAWAM, Mass., Dec. 1 /PRNewswire/ -- Even as the combination products market continues to experience dramatic growth, the approval process facing manufacturers seeking to introduce new medical devices embedded with pharmaceutical or biologics Source: www.pharmalive.com FDA Reports On Food Supply Safety - Post Chronicle The U.S. Food and Drug Administration issued a report on the year-long implementation of its Food Protection Plan to protect domestic and imported foods. The plan, officials said, outlines strategies for prevention, intervention and response to food Source: www.postchronicle.com FDA: Novartis malaria pill shows superior results - PR Inside WASHINGTON (AP) - Federal regulators said Monday a combination drug from Novartis to treat malaria works better than older drugs already on the market. The Swiss drugmaker has asked the Food and Drug Administration to approve its Coartem pill for Source: www.pr-inside.com FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review - Phramalive.com SEATTLE, December 01, 2008 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the supplemental Source: www.pharmalive.com FDA Reports Significant Progress In Protecting Food Supply - eMaxHealth.com The U.S. Food and Drug Administration today released a report on its implementation of the Food Protection Plan that was launched a year ago to protect both domestic and imported food from accidental and intentional contamination. The Plan, which Source: www.emaxhealth.com Drug Shortages: Current Drug Shortages; Ultra-TechneKow DTE (Technetium Tc 99m Generator) NDA 17-243 (updated) Drug Shortages: Current Drug Shortages; Ultra-TechneKow DTE (Technetium Tc 99m Generator) NDA 17-243 (updated)
Updated letter on this current drug shortage Drug Shortages: Drugs to be Discontinued; Nimotop (nimodipine) capsules Drug Shortages: Drugs to be Discontinued; Nimotop (nimodipine) capsules
See Web site for additional information Sun loses $3-bn revenue potential from US - Business Standard Sun loses $3-bn revenue potential from US - Business Standard
Sun Pharmaceutical Industries, India's largest drug maker by market value, has lost out on a $3-billion revenue potential from the US market after a rival beat it to gain the US regulator’s approval to sell the world’s best-selling anti Source: www.business-standard.com Gunmen kill Afghan official - CNN KABUL, Afghanistan (CNN) -- Two men on motorbikes shot dead the administrative chief of a district in southeastern Afghanistan Monday morning, an attack for which the Taliban later claimed responsibility. The gunmen killed Abdul Rahim Desiwal Source: edition.cnn.com Zapping depression - Philadelphia Inquirer In the late 1700s, Italian anatomist Luigi Galvani made a dead frog's muscles twitch when struck by a spark, a discovery that paved the way for the modern understanding of electricity's role in living things. It is the basis for countless medical Source: www.philly.com Early detection key to FDA food safety effort - Boston Globe After years of being criticized for its response to food-sickness outbreaks and contaminated imports, the Food and Drug Administration is stepping up efforts to convince the public and skeptical lawmakers that it is making progress in overhauling the Source: www.boston.com FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review - MSN MoneyCentral SEATTLE , Dec. 1 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review status for, the Source: news.moneycentral.msn.com Recalls and Safety Alerts: Serious Fungal Infections with Humira, Cimzia, Enbrel and Remicade Recalls and Safety Alerts: Serious Fungal Infections with Humira, Cimzia, Enbrel and Remicade
The manufacturers of Humira (adalimumab), Cimzia (certolizumab pegol), Enbrel (etanercept), and Remicade (infliximab) must strengthen warnings about the risk of developing opportunistic fungal infections from these drugs. These infections have been ... Recalls and Safety Alerts: Serious Muscle Injury with Simvastatin/Amiodarone Combination FDA is reminding healthcare professionals that patients who take amiodarone along with drugs that contain simvastatin have an increased risk of rhabdomyolysis, a type of muscle injury that can lead to kidney failure and death. Amiodarone is an antia... Preventing Medical Errors: Tragic Events with Concentrated Opiate Oral Solutions An alert from the Institute for Safe Medication Practices warns about potentially fatal errors that can occur with concentrated oral opiate solutions. ISMP cites a recent case involving an 18 year old who was prescribed oxycodone oral solution to ... FDA Acts to Avoid Shortage and Strengthen the Safety of Sucraid The U.S. Food and Drug Administration today issued an expedited approval of a supplemental application that allows for changes in the manufacturing of Sucraid (sacrosidase) Oral Solution. FDA Approves New Drug to Treat Severe Form of Epilepsy The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome. Recalls and Safety Alerts: Importance of Influenza Vaccination for Health Care Personnel As the flu season approaches, FDA is urging healthcare facilities to ensure that influenza vaccination programs are available for their personnel. Vaccinating healthcare workers will decrease the likelihood that they will contract influenza, and als... FDA Reports Nationwide Recall of Mislabeled ReliOn Insulin Syringes The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed hypodermic needles due to possible mislabeling. The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death. FDA Warns Public of Extortion Scam by FDA Impersonators The U.S. Food and Drug Administration is warning consumers about a fraudulent scheme to extort money from consumers by callers who falsely identify themselves as "FDA special agents" or other FDA officials. November 30, 2008UPDATE 1-NicOx at 6-month high as third trial backs drug - Reuters UPDATE 1-NicOx at 6-month high as third trial backs drug - Reuters
LONDON, Nov 24 (Reuters) - French biotech company NicOx (NCOX.PA: Quote , Profile , Research , Stock Buzz ) said on Monday its experimental arthritis treatment naproxcinod had proved to be safe and effective -- without raising blood pressure -- in a Source: www.reuters.com Banzel Drug Approved by FDA to Cure Severe Epilepsy - eNews 2.0 A severe form of epilepsy called Lennox-Gastaut syndrome will be treated with a new drug called Banzel, which has been approved by the Food and Drug Administration on Friday as an extra supplement against the terrible disease. The FDA approved the Source: www.enews20.com 'FDA special agent' calls are frauds - Baltimore Sun 'FDA special agent' calls are frauds - Baltimore Sun
Beware of an extortion scheme by callers who falsely identify themselves as "FDA special agents" or other FDA officials, according to the U.S. Food and Drug Administration. Several cases have been reported of callers enticing consumers to purchase Source: www.baltimoresun.com FDA Decides To Allow Melamine in Baby Formula - Eflux Media The Food and Drug Administration has recently released a report which states that the industrial chemical melamine is safe in baby formula in small amounts. The FDA had said before finding the contamination that melamine might be harmful in infant Source: www.efluxmedia.com Morning After Pill Now More Accessible - Redorbit.com A survey of pharmacies in three large U.S. cities showed women have easier and quicker access to the morning after pill since the Food and Drug Administration ruled the medication could be sold to adults without a prescription. The FDA approved Source: www.redorbit.com Immigration judge denies request to stay by IRA militant who has lived - Minneapolis Star Tribune HOUSTON - A former IRA militant living in the United States for nearly 25 years has been denied the right to remain in the country. Pol (PAUL) Brennan's attorney was notified of the decision Friday. A spokeswoman for the immigration courts says the Source: www.startribune.com Trace Levels of Melamine in Infant Formula Are Safe, FDA Says - Eflux Media Just days after the US Food and Drug Administration found traces of the industrial chemical melamine in some samples of infant formula, the agency wants to assure us that the quantity does not pose any threat to our kids. Dr. Stephen Sundlof Source: www.efluxmedia.com FDA sets melamine standard for baby formula - Hanford Sentinel WASHINGTON - Two months ago, federal food regulators said they were unable to set a safety threshold for the industrial chemical melamine in baby formula. Now, however, they found a way to settle on a standard that allows for higher levels than those Source: www.hanfordsentinel.com Consumers need better oversight of food imports - San Francisco Gate Sunday, November 30, 2008 Chances are good that you have consumed one of these products recently, or will in the coming days and weeks. If any of them are from China - and no, you may not be able to tell by looking at the label - then you may want to Source: www.sfgate.com Lilly withdraws Cymbalta - New Haven Register INDIANAPOLIS (AP) — Drugmaker Eli Lilly and Co. withdrew an application to have its antidepressant Cymbalta approved as a treatment for chronic pain, but the company said Friday it will apply again in 2009. Eli Lilly had filed a supplemental new Source: www.nhregister.com Melamine scare shows difficulty of policing food - Philiy.com Walk into an Asian grocery store, and you get a small taste of what the U.S. Food and Drug Administration is up against when it tries to track down products that may be tainted with the chemical melamine. Shelves overflow with brightly colored labels Source: www.philly.com FDA Decides To Allow Melamine in Baby Formula - Eflux Media FDA Decides To Allow Melamine in Baby Formula - Eflux Media
The Food and Drug Administration has recently released a report which states that the industrial chemical melamine is safe in baby formula in small amounts. The FDA had said before finding the contamination that melamine might be harmful in infant Source: www.efluxmedia.com AstraZeneca May Have to Delay Lung Drug - Street.Com AstraZeneca said Friday that the FDA had requested more information on Motavizumab, a drug used to prevent a type of lung infection in babies. AstraZeneca had been planning to get Motavizumab, used to prevent respiratory syncytial virus, to market in Source: www.thestreet.com FDA sets melamine standard for baby formula - NWI.com WASHINGTON - Two months ago, federal food regulators said they were unable to set a safety threshold for the industrial chemical melamine in baby formula. Now, however, they found a way to settle on a standard that allows for higher levels than those Source: www.thetimesonline.com How a leaf could reverse the fortunes of soft drink makers - Boston Globe SANTIAGO, Chile - A leaf the Guarani Indians of Paraguay's jungles used to sweeten drinks for centuries may help Coca-Cola Co. and PepsiCo Inc. revive flagging sales in the $320 billion-a-year global soft drink industry. The Food and Drug Source: www.boston.com FDA sets melamine standard for baby formula - Hanford Sentinel FDA sets melamine standard for baby formula - Hanford Sentinel
WASHINGTON - Two months ago, federal food regulators said they were unable to set a safety threshold for the industrial chemical melamine in baby formula. Now, however, they found a way to settle on a standard that allows for higher levels than those Source: www.hanfordsentinel.com 'FDA special agent' calls are frauds - Baltimore Sun Beware of an extortion scheme by callers who falsely identify themselves as "FDA special agents" or other FDA officials, according to the U.S. Food and Drug Administration. Several cases have been reported of callers enticing consumers to purchase Source: www.baltimoresun.com How a leaf could reverse the fortunes of soft drink makers - Boston Globe SANTIAGO, Chile - A leaf the Guarani Indians of Paraguay's jungles used to sweeten drinks for centuries may help Coca-Cola Co. and PepsiCo Inc. revive flagging sales in the $320 billion-a-year global soft drink industry. The Food and Drug Source: www.boston.com Cheap food may bring next health crisis - San Francisco Gate Sunday, November 30, 2008 The past decade witnessed the massive offshoring of jobs to low-cost countries, decimating the U.S. manufacturing base. Today, Americans are being challenged by the financial crisis, which has left much of the service Source: www.sfgate.com A sweet new entry in bitter food fight - Chicago Tribune Type in "aspartame" or "sucralose" into a search engine, and you're bound to come up with all sorts of hits linking the two artificial sweeteners to some sort of malady. Never mind that the Food and Drug Administration says they are safe. Now, the Source: www.chicagotribune.com Melamine scare shows difficulty of policing food - Philiy.com Walk into an Asian grocery store, and you get a small taste of what the U.S. Food and Drug Administration is up against when it tries to track down products that may be tainted with the chemical melamine. Shelves overflow with brightly colored labels Source: www.philly.com FDA Opens Offices in Beijing, Guangzhou and Shanghai - Eflux Media The Food and Drug Administration has decided to take an important step when it comes to consumer safety. Thus, three offices will be opened in China this week. The FDA is taking measures to ensure the quality and safety of the products exported to Source: www.efluxmedia.com Consumers need better oversight of food imports - San Francisco Gate Sunday, November 30, 2008 Chances are good that you have consumed one of these products recently, or will in the coming days and weeks. If any of them are from China - and no, you may not be able to tell by looking at the label - then you may want to Source: www.sfgate.com FDA sets standard for infant formula - Vacaville Reporter WASHINGTON (AP) -- Two months ago, federal food regulators said they were unable to set a safety threshold for the industrial chemical melamine in baby formula. Now, however, they found a way to settle on a standard that allows for higher levels than Source: www.thereporter.com |
Subscribe to Posts [Atom]